Atlas Trials

Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris

Clinical trial NCT01498874 · COMPLETED

Trial details

NCT number
NCT01498874
Sponsor
XOMA (US) LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2011-12-01
Primary completion
2013-04-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.